title: Efficacy of an inhaled corticosteroid/long-acting β2-agonist combination in symptomatic COPD patients in GOLD groups B and D.
authors.affiliation: Department of Pulmonary/Critical Care, University of Texas Health Sciences Centre, and South Texas Veterans Healthcare System, San Antonio, TX, USA anzueto@uthscsa.edu.
authors.forename: Antonio
authors.initials: A
authors.lastname: Anzueto
authors.affiliation: The George Institute for Global Health, Sydney, Australia.
authors.forename: Christine R
authors.initials: CR
authors.lastname: Jenkins
authors.affiliation: Division of Pulmonary Sciences and Critical Care Medicine, National Jewish Health, University of Colorado, Denver, CO, USA.
authors.forename: Barry J
authors.initials: BJ
authors.lastname: Make
authors.affiliation: AstraZeneca R&D, Mölndal, Sweden.
authors.forename: Magnus
authors.initials: M
authors.lastname: Lindberg
authors.affiliation: Pulmonary and Rehabilitation Research Group, University Hospital Aintree, Liverpool, UK.
authors.forename: Peter M
authors.initials: PM
authors.lastname: Calverley
authors.affiliation: AstraZeneca R&D, Mölndal, Sweden.
authors.forename: Malin
authors.initials: M
authors.lastname: Fagerås
authors.affiliation: University of Groningen, University Medical Center Groningen, GRIAC Research Institute, The Netherlands.
authors.forename: Dirkje S
authors.initials: DS
authors.lastname: Postma
authors.affiliation: Division of Pulmonary, Critical Care, Sleep and Allergy, University of Nebraska Medical Center, Omaha, NE, USA.
authors.forename: Stephen I
authors.initials: SI
authors.lastname: Rennard
authors.affiliation: David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.
authors.forename: Donald P
authors.initials: DP
authors.lastname: Tashkin
mesh_terms: D000280:Administration, Inhalation; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage*; D058666:Adrenergic beta-2 Receptor Agonists / Q000008:administration & dosage*; D000368:Aged; D001993:Bronchodilator Agents / Q000008:administration & dosage; D019819:Budesonide / Q000008:administration & dosage; D005260:Female; D005541:Forced Expiratory Volume; D000068759:Formoterol Fumarate / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008875:Middle Aged; D016016:Proportional Hazards Models; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*; D012907:Smoking; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D058666:Adrenergic beta-2 Receptor Agonists; D001993:Bronchodilator Agents; D019819:Budesonide; D000068759:Formoterol Fumarate